Key insights
- SpaceX has reportedly filed confidentially for an IPO, potentially the largest ever with a valuation around $1.75 trillion. Eli Lilly's obesity pill received US approval, boosting LLY stock and intensifying competition with Novo Nordisk. US stocks opened higher amid hopes of de-escalation in Iran, with President Trump expected to address the nation on the matter.
Yahoo Finance Senior Producer John Hyland tracks today's top moving stocks and biggest market stories in this Market Minute.
US stocks (^DJI, ^GSPC, ^IXIC) kick off the second quarter of 2026 ahead of President Trump's address to the nation on Wednesday at 9 P.M.
Elon Musk's SpaceX (SPAX.PVT) has reportedly filed confidentially for an IPO, according to Bloomberg.
Eli Lilly's (LLY) stock rises after its obesity pill gets approval by US regulators, intensifying competition with Novo Nordisk (NVO).
It's time for your Yahoo Finance Market Minute. I'm John Highland.
We are halfway into the trading day on the first day of the second quarter. We're seeing stocks kick off trading in the green, uh this coming amid some hopes of de-escalation with the war in Iran.
We will get the latest insight tonight when President Trump addresses the nation in a primetime speech at 9:00 p.m. Eastern Time, which is expected to address the war in Iran.
Switching it up, I want to take a look at SpaceX. The company has reportedly filed confidentially for its IPO.
It would be one of the largest IPOs ever, if not the largest IPO ever. It would have a valuation of around $1.75 trillion according to Bloomberg,
and it could raise up to $75 billion in that public offering.
And then finally, I want to take a look at Eli Lilly. It's uh heating up its battle with weight loss rival Novo Nordisk.
Uh the company won US approval um for its obesity pill.
Uh Lilly's pill will be called Foundeo and be a once- daily pill that could cost as little as $149 for patients who pay in cash.
So seeing a positive reaction in the share price today up nearly 5% on the day.